Trials / Conditions / Metastatic Triple Negative Breast Cancers
Metastatic Triple Negative Breast Cancers
4 registered clinical trials studyying Metastatic Triple Negative Breast Cancers — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Sac-TMT for Active TNBC Brain Metastases NCT07458113 | Yale University | Phase 2 |
| Recruiting | Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer NCT06774027 | University of California, San Francisco | — |
| Active Not Recruiting | Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Co NCT06449222 | BioNTech SE | Phase 2 |
| Recruiting | Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer NCT05035745 | National University Hospital, Singapore | Phase 1 / Phase 2 |